#urologydevices

[market-insider]

Urology Ultrasound Devices Market Trends and Analysis: Comprehensive Overview of Market Size, Growth

The global urology ultrasound devices market surged to an estimated USD 1.21 billion in 2024 and is projected to reach approximately USD 1.29 billion in 2025, before climbing to USD 1.74 billion by 2030, a steady CAGR of 6.17% for the 2025-2030 period.

What’s driving this momentum?

The growing prevalence of urological disorders-from prostate cancer and benign prostatic hyperplasia (BPH) to kidney stones-especially in aging populations.

Innovations like AI-enhanced imaging and portable/hand-held devices are making diagnostics faster, smarter, and more accessible.

Spotlight Segments: Prostate Leads, Diagnostics Shifts, and Regions to Watch

Prostate Disorders: Clear Front-Runner

The prostate disorders segment accounted for the largest share at 36.8% in 2024, and it's also expected to grow the fastest-driven by aging male demographics and rising diagnosis rates.

Diagnostics Centers: A Rapid Move

Diagnostic imaging centers will see the fastest growth among end-use segments, with a compelling CAGR of 6.41%. Accessibility, quality care, and tech advancements are pulling patients closer to outpatient solutions.

Regional Outlook: North America Leads; Asia Pacific Booms

North America held a dominant 41.4% global share in 2024, powered by top-tier healthcare infrastructure and big players like Philips, GE Healthcare, and Siemens driving AI and portable innovations.

In the U.S., the market stood at USD 394.8 million in 2024 and is forecasted to grow to USD 542.7 million by 2030, at a CAGR of 5.5%.

Meanwhile, Asia Pacific is projected to post the fastest growth overall, at a CAGR of 7.20%, thanks to rising healthcare investment and growing demand across China, India, Japan, and Southeast Asia.

For More Details or Sample Copy please visit link @: Urology Ultrasound Devices Market

Why It Matters (And Why You Should Care)

Urology ultrasound devices are no longer fuddy-duddy tech-they’re lifelines. With real-time, non-invasive, and increasingly intelligent diagnostics, these tools are transforming early detection and treatment across the globe. Aging demographics and rising chronic and lifestyle-linked urological diseases only intensify that demand.

Tech advances-primarily AI, improved portability, and imaging fidelity-are not just nice to have; they’re essential disruptors reshaping how clinicians work and how patients get diagnosed faster and with more confidence.

Final Word: No More Industry Stagnation

This isn’t your grandma’s diagnostics market. Growth is solid. Innovation is relentless. And the demand is only going up. Anyone not paying attention to the urology ultrasound space is going to get left behind.

Let me know if you want to punch up this into a full press release including quotes, hypothetical branding, or investor call hooks.

[market-insider]

Strategic Assessment of the Urolithiasis Management Devices Market

The global urolithiasis management devices market was valued at USD 2.21 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 4.9% from 2023 to 2030. The alarming growth in the incidence rate of urinary stones, over the years, is responsible for the advancements in the treatment options. European Association of Urology states that it is one of the most common lifestyle disorders with a 10% prevalence rate and requires a systematic treatment approach.

Urolithiasis means formation of stones in the urinary system, mainly including the kidney, ureters, and the bladder. It is a major healthcare concern in the high end countries such as the U.S., Canada, and Germany with a recurrence rate of 50% in most of the cases. Urolithiasis can be managed with the help of lifestyle changes, controlled diet, or basic medication. However, various treatment approaches need to be adopted for the removal of large stones that cause severe pain. Depending upon the stone size, location in the body, and anatomical variations in the urogenital tract, invasive or noninvasive stone removal procedures are available. For instance, smaller stones can be tackled with external shock waves (extracorporeal shock wave lithotripsy), while larger stones can be removed through surgeries (intracorporeal lithotripsy or percutaneous nephrolithotomy).

Smaller stones generally do not require surgical interventions and can be cured with the help of medication and a healthy diet. However, larger stones necessitate different approaches for their elimination. Extracorporeal lithotripsy is one of the common treatments employed for stone elimination and held a majority market share in the year 2015. Intracorporeal lithotripsy treatments spot and reduce the stones to smaller pieces with the help of endoscopy. For the disintegration of stones, ultrasound or laser techniques are used to enable the passage of smaller fragments through the urinary system. Owing to the effective stone-free rate offered by intracorporeal lithotripsy, it is likely to be preferred as a treatment option during the forecast period.

Furthermore, percutaneous nephrolithotomy is a surgical approach deployed to eliminate larger stones where extracorporeal or intracorporeal lithotripsies prove to be ineffective and typically require a week’s hospitalization.

Ambulatory surgical centers are gaining popularity over traditional hospital and clinic settings due to the time and cost saving benefits. As a result, this end-use segment is expected to record a lucrative growth rate during the forecast period. Introduction of novel surgical technologies, such as endoscopy and micro accessories including guidewires, scalpels, and baskets, to effectively expel stones from the urinary system in a short time has enhanced the overall acceptability of minimally invasive surgeries.

Request a free sample copy or view report summary: Urolithiasis Management Devices Market Report